Abacus Planning Group Inc. Has $392,000 Position in HCA Healthcare, Inc. $HCA

Abacus Planning Group Inc. reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 11.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,024 shares of the company’s stock after selling 136 shares during the period. Abacus Planning Group Inc.’s holdings in HCA Healthcare were worth $392,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Hilltop National Bank bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $156,000. Mirae Asset Global Investments Co. Ltd. grew its position in shares of HCA Healthcare by 4.9% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,837 shares of the company’s stock valued at $9,515,000 after acquiring an additional 1,153 shares during the period. Metropolis Capital Ltd grew its position in shares of HCA Healthcare by 76.6% in the 2nd quarter. Metropolis Capital Ltd now owns 603,029 shares of the company’s stock valued at $231,020,000 after acquiring an additional 261,592 shares during the period. Pure Financial Advisors LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $247,000. Finally, Childress Capital Advisors LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $232,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently commented on HCA. JPMorgan Chase & Co. lifted their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Wells Fargo & Company reduced their target price on shares of HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating for the company in a report on Thursday, August 14th. Morgan Stanley reduced their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a report on Monday, July 28th. Finally, Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $407.75.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by insiders.

HCA Healthcare Stock Up 0.2%

HCA opened at $426.81 on Friday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $429.43. The stock has a market capitalization of $99.87 billion, a price-to-earnings ratio of 17.94, a P/E/G ratio of 1.34 and a beta of 1.40. The company has a 50-day simple moving average of $395.62 and a 200 day simple moving average of $371.70.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the firm posted $5.50 EPS. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.